Cargando…
Sepsis and ARDS: The Dark Side of Histones
Despite advances in management over the last several decades, sepsis and acute respiratory distress syndrome (ARDS) still remain major clinical challenges and the leading causes of death for patients in intensive care units (ICUs) due to insufficient understanding of the pathophysiological mechanism...
Autores principales: | Xu, Zhiheng, Huang, Yongbo, Mao, Pu, Zhang, Jianrong, Li, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644547/ https://www.ncbi.nlm.nih.gov/pubmed/26609197 http://dx.doi.org/10.1155/2015/205054 |
Ejemplares similares
-
Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
por: Xu, Zhiheng, et al.
Publicado: (2021) -
β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012) -
The dark side of histones: genomic organization and role of oncohistones in cancer
por: Amatori, Stefano, et al.
Publicado: (2021) -
Survival Predictors for Severe ARDS Patients Treated with Extracorporeal Membrane Oxygenation: A Retrospective Study in China
por: Liu, Xiaoqing, et al.
Publicado: (2016) -
Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis
por: Li, Xi, et al.
Publicado: (2018)